Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p((R)) and carboxymethylcellulose.

[1]  N Verbeke,et al.  Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems. , 2000, International journal of pharmaceutics.

[2]  R. Sciot,et al.  Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  G. Van den Mooter,et al.  Nasal mucoadhesive delivery systems of the anti-parkinsonian drug, apomorphine: influence of drug-loading on in vitro and in vivo release in rabbits. , 1999, International journal of pharmaceutics.

[4]  M. Durrani,et al.  Acrylic polymers: A review of pharmaceutical applications , 1997 .

[5]  M. Donovan,et al.  Intranasal mucociliary clearance of putative bioadhesive polymer gels , 1996 .

[6]  T. Nagai,et al.  In vitro and in vivo nasal mucoadhesion of some water-soluble polymers , 1996 .

[7]  H. Zia,et al.  Bioadhesive and formulation parameters affecting nasal absorption , 1996 .

[8]  Y. Chien.  Biopharmaceutics basis for transmucosal delivery , 1995 .

[9]  P. Artursson,et al.  Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions. , 1995, Journal of drug targeting.

[10]  P. Augustijns,et al.  Stability of apomorphine in plasma and its determination by high-performance liquid chromatography with electrochemical detection. , 1994, Journal of chromatography. B, Biomedical applications.

[11]  S. S. Davis,et al.  Nasal Absorption of Desmopressin in Rats and Sheep. Effect of a Bioadhesive Microsphere Delivery System , 1994, The Journal of pharmacy and pharmacology.

[12]  B. Bake,et al.  Influence of degradable starch microspheres on the human nasal mucosa. , 1994, Rhinology.

[13]  P. Artursson,et al.  Mechanisms of absorption enhancement and tight junction regulation , 1994 .

[14]  Claus-Michael Lehr,et al.  Bioadhesive polymers for the peroral delivery of peptide drugs , 1994 .

[15]  P. Colombo,et al.  Nasal powders of progesterone : manufacturing and bioavailability , 1994 .

[16]  S. Gizurarson.  The relevance of nasal physiology to the design of drug absorption studies , 1993 .

[17]  N. Peppas.  Buccal and nasal administration as an alternative to parenteral administration , 1993 .

[18]  S. Mortazavi,et al.  An investigation into the role of water movement and mucus gel dehydration in mucoadhesion , 1993 .

[19]  P. Paronen,et al.  In vitro evaluation of spray-dried mucoadhesive micropheres for nasal administration. , 1992 .

[20]  P. Paronen,et al.  Double-labelling technique in the evaluation of nasal mucoadhesion of disodium cromoglycate microspheres , 1991 .

[21]  J. Nutt,et al.  Absorption of apomorphine by various routes in parkinsonism , 1991, Movement disorders : official journal of the Movement Disorder Society.

[22]  Clive G. Wilson,et al.  The influence of solution viscosity on nasal spray deposition and clearance , 1988 .

[23]  G. Liversidge,et al.  Nasal delivery of a vasopressin antagonist in dogs. , 1988, Journal of applied physiology.

[24]  Hans Bisgaard,et al.  Bioadhesive microspheres as a potential nasal drug delivery system , 1987 .

[25]  N. Peppas,et al.  BIOADHESIVE ANALYSIS OF CONTROLLED-RELEASE SYSTEMS. I. FRACTURE AND INTERPENETRATION ANALYSIS IN POLY(ACRYLIC ACID)-CONTAINING SYSTEMS , 1987 .

[26]  J. Robinson,et al.  Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion☆ , 1985 .

[27]  Nagai Tsuneji,et al.  Powder dosage form of insulin for nasal administration , 1984 .

[28]  E. Puchelle,et al.  Comparison of three methods for measuring nasal mucociliary clearance in man. , 1981, Acta oto-laryngologica.

[29]  F. Aoki,et al.  Distribution and removal of human serum albumin-technetium 99m instilled intranasally. , 1976, British journal of clinical pharmacology.